- Report
- October 2024
- 197 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 194 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- July 2024
- 150 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- December 2024
- 120 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- July 2024
- 100 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- February 2024
- 119 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- May 2023
- 147 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- May 2022
- 105 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- May 2022
- 83 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- March 2024
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Report
- March 2024
- 132 Pages
Global
From €903EUR$950USD£759GBP
Neuroendoscopy is a minimally invasive surgical procedure used to diagnose and treat a variety of neurological disorders. It involves the insertion of a thin, flexible tube with a camera and light source into the brain or spinal cord through a small incision. This allows the surgeon to view the area of interest and perform procedures such as biopsies, tumor resection, and cyst drainage. Neuroendoscopy is a safe and effective alternative to traditional open brain surgery, offering shorter recovery times and fewer complications.
Neuroendoscopy is used to treat a variety of neurological conditions, including hydrocephalus, brain tumors, and intracranial cysts. It is also used to diagnose and treat conditions such as epilepsy, stroke, and traumatic brain injury. The procedure is increasingly being used in pediatric patients, as it is less invasive and offers a shorter recovery time than traditional open brain surgery.
Some companies in the Neuroendoscopy market include Karl Storz, Stryker, Medtronic, Olympus, and Richard Wolf. Show Less Read more